NeuroMetrix Announces $5 Million Preferred Stock Placement WALTHAM, Mass. --(BUSINESS WIRE)--Jun. 4, 2013-- NeuroMetrix, Inc. (Nasdaq:NURO) (the "Company" or "NURO"), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today announced that

Launch of SENSUS™ Pain Management Device Highlights the Quarter

NeuroMetrix to Partner with Omron Healthcare for Distribution of NC-stat DPNCheck in Japan WALTHAM, Mass. --(BUSINESS WIRE)--Apr. 24, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), announced that it had entered

NeuroMetrix, Inc. Announces Date for 2013 First Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Apr. 17, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), today said it plans to issue its 2013 first quarter financial results before the opening of the market on April 25, 2013 .

NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of Korea WALTHAM, Mass. --(BUSINESS WIRE)--Mar. 12, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of

NeuroMetrix Reports Q4 2012 Results WALTHAM, Mass. --(BUSINESS WIRE)--Feb. 19, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and

Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on February 19, 2013

NeuroMetrix, Inc. Announces Date for 2012 Full Year and Fourth Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Feb. 12, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , today said it plans to issue its 2012 full year and fourth quarter financial results

NeuroMetrix Launches Website for SENSUS™ Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 30, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that is

NeuroMetrix Announces Initial Commercial Shipment of SENSUS™ Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Jan. 7, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,